Introduction
============

SIAE is involved in the maintenance of immunological tolerance through negative regulation of Β-cell receptor (BCR) signaling. Recent evidences, though conflicting, indicate that rare loss-of-function *SIAE*variants are associated with susceptibility to various autoimmune diseases. Advances in understanding JIA pathophysiology have led to the consensus that systemic JIA (SJIA) is an autoinflammatory disorder while oligo/polyarticular JIA (O/PJIA) is an antigen-driven lymphocyte-mediated autoimmune disease.

Objectives
==========

To elucidate whether *SIAE*variants predispose their carriers to O/PJIA but not to SJIA.

Methods
=======

Sixty-five JIA patients (M/F: 19/46, mean age: 9.8 years, range:2.5-18.3; 57 with O/PJIA and 8 with SJIA) and 82 age- and sex-matched healthy controls were enrolled. Amplification of all 10 *SIAE*exons, including exon-intron boundaries, and sequencing of purified products were performed.

Results
=======

Two novel heterozygous *SIAE*mutations, namely the Q343P (g.41498 A \> C, c.1028A \> C) and the Y495X (g.44266C \> A, c.1485C \> A), as well as three already described heterozygous *SIAE*mutations, namely the functionally innocent M89V (g.20536A \> G) mutation and the silent mutations S156S (g.26573T \> C) and T484T (g.44233G \> A) were found in O/PJIA patients. The girl carrying the Q343P mutation had ANA(+) persistent oligoarthritis. Her family study proved that her father, having a family history of autoimmune disease, was also carrier of the same mutation. The girl with the Y495X mutation suffered from RF(-), ANA(+) polyarthritis. The novel *SIAE*mutations did not detected among normal controls. Amongst the patients with SJIA, one was heterozygote for the known functionally innocent K71R (g.11927A \> G) and A467V (g.44181C \> T) mutations as well as for the silent mutations T484T and S156S, while another one was heterozygote for the silent mutation R340R (g. 41490 T \> C).

Conclusion
==========

Our results support the notion that SIAE might be involved to the pathogenesis of O/PJIA but not of SJIA. Functional analysis of the identified novel *SIAE*variants is required to prove the biological significance of these genetic alterations.
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